Groups
Company Size (Fulltime employees)
Looking for
Functionality
Headquartner in China
Biotech/Pharma Category
Biotech/Pharma Asset Stage
Medtech Category
Medtech Development Stage
Index
Countries
Reset

Tractivus SL Spain

TRACTIVUS is a company derived from the research group GEMAT (IQS-Ramón Llull University) and IDIBELL (Bellvitge Biomedical Research Institute), located in Barcelona. We are an innovative company with expertise in antibacterial coatings, easy to be implemented on a wide range of medical devices.

PHOBOSTech™ technology have been developed over the years in Tractivus SL as a solution to the current problems of medical devices. Our cost-effective patented technology allows to create nanostructures on the surface, preventing bacteria attachment and, therefore, bacteria colonization. As a result our devices show higher lifetime, lower associated costs, and no post-implantation problems without adverse effect on the patients.

Tractivus SL combines the experience of the research groups and a unique solution designed to root out the colonization of the devices through a micro- and nano-structured coating that protects the device from adhesion and bacterial colonization. The team has worked on all aspects of the development: material selection, regulatory strategy, risk reduction, clinical trials, partners, stakeholders... aiming to maximize the success of both the project and the investors.
Website:
https://www.tractivus.com/
Company Size (Fulltime employees)
1-10
Year of foundation
2015
Looking for
Please specify your partnering goal
Establish commercial out-license agreement to bring our product to the market
Headquartner in China
No
Plan in China
We are looking for partners to grow up and achieve the NMPA certificates, clinical studies and markers in Asia. We are interested in manufacture and distributor partners in China for our technology and, also, we are looking for potential license-customers for medical devices modification.
Biotech/Pharma Category
Medtech Category
Medtech Information 1, Device Name|Description|Development Stage|Licensed Countries
PHOBOSTech|Bacteriophobic/Bacteriostatic/Bactericide coating for streacheable silicone-based surfaces|Full developed|-
Medtech Information 2
UroPHOB|Foley urinary catheter with PHOBOSTech tecnology|Scale lab validated/Preclinical test performed/Designing clinical test|-
Medtech Development Stage
Joan Gilabert
Joan Gilabert
CEO 
Functionality
Management

Wanbang Biopharmaceuticals (Group) Co., Ltd China

Wanbang Biopharmaceuticals (Wanbang Biopharma) is a core member of Shanghai Fosun PHARMACEUNCAL (group) Co., Ltd.(Fosun Pharma”, Stock code: 600196-SH,02196-HK).
Website:
Chinawanbang.com
Looking for
Headquartner in China
Yes
Biotech/Pharma Category
Service Description
Therapeutic products: Diabetes, anti-tumor, Chronic kidney disease, cardiovascular drug,etc.
Dr Di Simon
高级BD经理 

WPD Pharmaceuticals Canada

WPD has 8 novel drug candidates with 4 that are in clinical development stage and 4 in pre-clinical development. These drug candidates were researched at institutions including the Mayo Clinic and Emory University, and WPD currently has ongoing collaborations with Wake Forest University and leading hospitals and academic centers in Poland.

Alongside direct investment of $60 million, over $29 million of grant funding (total of $89 million USD) has gone towards the development of our robust drug development pipeline with a focus on melanoma, brain cancer, leukemia, and pancreatic cancer. Notably, these funds do not include $14 million USD in grants recently awarded to WPD Pharmaceuticals from The National Centre for Research and Development in Poland.

With a groundswell of multi-continental grant support and a diverse portfolio of breakthrough drug technologies, WPD Pharmaceuticals is now strategically positioned to enter the market with blockbuster potential.

Website:
https://www.wpdpharmaceuticals.com/about/overview/
Company Size (Fulltime employees)
11-50
Year of foundation
2017
Stock Market and Ticker/Symbol/Number
WCSE: BIO
Looking for
Please specify your partnering goal
We are looking for investors and partners for co-develop our product in China and co-develop partner product in EU.
Now raising (In USD)
between $ 3 million - $10 million
Headquartner in China
No
Plan in China
We are looking for investors and partners for co-develop our product in China and co-develop partner product in EU.
Biotech/Pharma Category
Investment Focus
Seeking funding to move from pre clinical stage to Phase 1/2 clinical trial and support co-development in EU
Mariusz Olejniczak
CEO 
Functionality
Management

华润双鹤药业 China

央企,从事药品研发,生产,销售,产品超过300个,2019年营业收入将近100亿元,共有400人的研发团队,全国分布19个生产基地,销售网络遍布全国各省,销售团队超过2500人。希望寻找高壁垒仿制药,高端技术平台,505b2,创新化药,生物药&生物类似物的合作机会,合作方式灵活。
Website:
www.dcpc.com
Looking for
Headquartner in China
Yes
Biotech/Pharma Category
Service Description
Therapeutic products
怡 李
BD经理 

成都百裕制药股份有限公司 China

Baiyu , founded in 2005, is a pharmaceutical enterprise engaged in developing, manufacturing and distributing of high-quality pharmaceutical products and APIs. With about 1000 employees, Baiyu now has 6 subsidiaries including Golden Ginkgo Pharmaceutical Co., Ltd., Ginkgolide Pharmaceuticals Co., Ltd., Sunshine Ginkgo Agriculture Co.Ltd., Sichuan Yu Jian Pharmaceutical Co., Ltd. and Ginkgo Yukang Informatics Co.,Ltd., Ginkgo Yuda Pharmaceutical Co.,Ltd., et al.

Currently,we have 8 finished pharmaceutical products and 2 APIs on the market. Based on Quality-by-Design concept, our manufacturing sites strictly comply with cGMP and EU GMP. Ginkgolide injection, Enoxaparin sodium injection, Lansoprazole for injection are our main products.

Baiyu is growing fastly and has been awarded“National High-tech Enterprise”,“Sichuan Famous Brand”and“Enterprises with the most investment value in Chinese pharmaceutical industry”in 3 consecutive years.

The culture of kindness, Taiji and phoenix leads the way we behave and our vision is to constantly benefiting mankind to enjoy life-long well-being.

Website:
http://www.baiyujituan.com/english.php?m=index&a=index
Looking for
Headquartner in China
Yes
Biotech/Pharma Category
Slides Deck
(pdf, 2.37MB)
Nicky 吕
Lv 
Functionality
Management